Today’s Solutions: August 17, 2022

On average, the pharmaceutical industry creates 100kg of waste for every 1kg of small-molecule drug synthesized. Making this process highly inefficient and creating a lot of toxic waste. Nitrogen-containing chemicals called primary amines are the sought-after chemicals from these processes, being used in the majority of all pharmaceuticals. Although this is far from ideal in our current climate, people need the life-saving medications produced through the process.

A research team from the University of Bath has come up with an ingenious idea to cut this waste down dramatically. Dr. Cresswell, the leader of the laboratory stated: “Making pharmaceuticals can be a wasteful process, with most of that waste being incinerated… People don’t really think about the pharmaceutical industry when it comes to carbon emissions, but some studies have calculated that big pharma emits more than the automotive industry.”

So how does it work?

The method uses a blue light-sensitive catalyst as the key player in the process. This molecule is able to capture energy from the light source, then channel it back into the reaction. The outcome? Dramatic acceleration of the drug-making process and the cutting out of many in-between steps. Scientists have been stumped trying to efficiently produce primary amines for decades, making the work published in the Journal of the American Chemical Society (JACS) an urgently needed discovery.

Applying the method to industry

The method was tested by synthesizing Fingolimod, a widely popular drug for multiple sclerosis (MS), which had worldwide sales in 2020 of €3 billion. The drug was able to be produced successfully, showing the huge potential of this method to revolutionize the industry.

“We’re really excited that our group is the first in the world to achieve this breakthrough, and hope that it could in the future lead to much more sustainable pharmaceutical manufacturing processes,” said Cresswell. In the meantime, whilst we wait for the industry to catch up, the discovery and development of drugs can be made easier and more environmentally friendly using this method.

Source study: Journal of the American Chemical Society (JACS)Photocatalytic Hydroaminoalkylation of Styrenes with Unprotected Primary Alkylamines

Solutions News Source Print this article
More of Today's Solutions

Why you should fill your cart with ugly watermelons

When it comes to picking produce at our local market or grocery store, many of us are… well… shallow. We tend to fill our carts with only the prettiest, most visually appealing fruits and veggies.  ... Read More

Add these 4 foods to your diet to reduce bloating

If your stomach has ever swollen to the point where you felt the urge to unbutton your pants, chances are bloating is to blame. The good thing is that bloating can usually be relieved with ... Read More

How ketamine can help fight depression

Quick acting aid A recent review from the University of Exeter, has shown that the sedative drug ketamine, has therapeutic effects in regards to mental health. The study, published in BJPsych Open, analyzed 83 papers ... Read More

Study: Exercise after vaccination may boost immunity

If you thought it was better to take it easy after getting your vaccine, you may want to think again. In a new study published by Brain, Behavior, and Immunity, researchers found that up to ... Read More